151 related articles for article (PubMed ID: 9930343)
1. Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase/ganciclovir gene therapy.
Duflot-Dancer A; Piccoli C; Rolland A; Yamasaki H; Mesnil M
Gene Ther; 1998 Oct; 5(10):1372-8. PubMed ID: 9930343
[TBL] [Abstract][Full Text] [Related]
2. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
3. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
[TBL] [Abstract][Full Text] [Related]
4. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
[TBL] [Abstract][Full Text] [Related]
6. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
7. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D
Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126
[TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene].
Gao G; Huang T; Chen S
Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):301-3. PubMed ID: 12133366
[TBL] [Abstract][Full Text] [Related]
9. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
Princen F; Robe P; Lechanteur C; Mesnil M; Rigo JM; Gielen J; Merville MP; Bours V
Clin Cancer Res; 1999 Nov; 5(11):3639-44. PubMed ID: 10589781
[TBL] [Abstract][Full Text] [Related]
10. Connexin 43-mediated bystander effect in two rat glioma cell models.
Sanson M; Marcaud V; Robin E; Valéry C; Sturtz F; Zalc B
Cancer Gene Ther; 2002 Feb; 9(2):149-55. PubMed ID: 11857032
[TBL] [Abstract][Full Text] [Related]
11. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments.
Coll JL; Mesnil M; Lefebvre MF; Lancon A; Favrot MC
Gene Ther; 1997 Nov; 4(11):1160-6. PubMed ID: 9425438
[TBL] [Abstract][Full Text] [Related]
14. Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43.
Cottin S; Ghani K; Caruso M
Cancer Gene Ther; 2008 Dec; 15(12):823-31. PubMed ID: 18600256
[TBL] [Abstract][Full Text] [Related]
15. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM
Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
18. Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line.
Drake RR; Pitlyk K; McMasters RA; Mercer KE; Young H; Moyer MP
Mol Ther; 2000 Nov; 2(5):515-23. PubMed ID: 11082325
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy.
Boucher PD; Ostruszka LJ; Murphy PJ; Shewach DS
Gene Ther; 2002 Aug; 9(15):1023-30. PubMed ID: 12101433
[TBL] [Abstract][Full Text] [Related]
20. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
Kong BH; Wang WX; Liu CS; Ma DX; Qu X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]